Janus Henderson Group
TEVA icon

Janus Henderson Group’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$86.6M Sell
5,164,890
-913,351
-15% -$15.3M 0.04% 291
2025
Q1
$91.7M Sell
6,078,241
-659,384
-10% -$9.94M 0.05% 276
2024
Q4
$148M Buy
6,737,625
+1,945,688
+41% +$42.9M 0.08% 227
2024
Q3
$86.4M Buy
4,791,937
+4,732,374
+7,945% +$85.3M 0.04% 297
2024
Q2
$968K Hold
59,563
﹤0.01% 1635
2024
Q1
$840K Hold
59,563
﹤0.01% 1739
2023
Q4
$622K Hold
59,563
﹤0.01% 1890
2023
Q3
$607K Sell
59,563
-6,943
-10% -$70.8K ﹤0.01% 1834
2023
Q2
$500K Sell
66,506
-12,004
-15% -$90.3K ﹤0.01% 1979
2023
Q1
$694K Hold
78,510
﹤0.01% 1839
2022
Q4
$716K Sell
78,510
-78,510
-50% -$716K ﹤0.01% 1534
2022
Q3
$1.27M Buy
157,020
+78,510
+100% +$633K ﹤0.01% 1525
2022
Q2
$591K Sell
78,510
-174,923
-69% -$1.32M ﹤0.01% 1662
2022
Q1
$2.38M Buy
253,433
+25,780
+11% +$242K ﹤0.01% 1178
2021
Q4
$1.82M Hold
227,653
﹤0.01% 1295
2021
Q3
$2.22M Sell
227,653
-22,436
-9% -$219K ﹤0.01% 1227
2021
Q2
$2.48M Buy
250,089
+41,616
+20% +$412K ﹤0.01% 1197
2021
Q1
$2.41M Buy
208,473
+5,326
+3% +$61.5K ﹤0.01% 1148
2020
Q4
$1.96M Sell
203,147
-21,244
-9% -$205K ﹤0.01% 1127
2020
Q3
$2.02M Buy
224,391
+33,114
+17% +$298K ﹤0.01% 1056
2020
Q2
$2.36M Buy
191,277
+63,790
+50% +$786K ﹤0.01% 1009
2020
Q1
$1.14M Sell
127,487
-170,377
-57% -$1.53M ﹤0.01% 1084
2019
Q4
$2.92M Sell
297,864
-367,784
-55% -$3.6M ﹤0.01% 1124
2019
Q3
$4.58M Sell
665,648
-688,287
-51% -$4.74M ﹤0.01% 1067
2019
Q2
$12.5M Buy
1,353,935
+1,100,481
+434% +$10.2M 0.01% 900
2019
Q1
$3.97M Sell
253,454
-1,033,267
-80% -$16.2M ﹤0.01% 1041
2018
Q4
$19.8M Buy
1,286,721
+1,145,300
+810% +$17.7M 0.01% 751
2018
Q3
$3.05M Buy
141,421
+14,500
+11% +$312K ﹤0.01% 1107
2018
Q2
$3.09M Hold
126,921
﹤0.01% 1094
2018
Q1
$2.17M Hold
126,921
﹤0.01% 1153
2017
Q4
$2.41M Sell
126,921
-115
-0.1% -$2.18K ﹤0.01% 1099
2017
Q3
$2.24M Sell
127,036
-3,011,051
-96% -$53M ﹤0.01% 1103
2017
Q2
$104M Sell
3,138,087
-740,856
-19% -$24.6M 0.07% 343
2017
Q1
$124M Sell
3,878,943
-4,227,409
-52% -$136M 0.87% 16
2016
Q4
$294M Buy
8,106,352
+253,376
+3% +$9.19M 2.17% 4
2016
Q3
$361M Buy
7,852,976
+185,562
+2% +$8.54M 2.66% 3
2016
Q2
$385M Buy
7,667,414
+2,130,847
+38% +$107M 3.2% 1
2016
Q1
$296M Buy
5,536,567
+966,585
+21% +$51.7M 2.4% 3
2015
Q4
$300M Buy
4,569,982
+2,312,491
+102% +$152M 2.41% 3
2015
Q3
$127M Buy
2,257,491
+408,465
+22% +$23.1M 1.12% 11
2015
Q2
$109M Sell
1,849,026
-193,444
-9% -$11.4M 0.86% 12
2015
Q1
$127M Sell
2,042,470
-19,363
-0.9% -$1.21M 0.98% 12
2014
Q4
$119M Sell
2,061,833
-38,110
-2% -$2.19M 0.85% 17
2014
Q3
$113M Buy
2,099,943
+563,830
+37% +$30.3M 1.06% 17
2014
Q2
$80.5M Buy
1,536,113
+127,930
+9% +$6.71M 0.75% 25
2014
Q1
$74.4M Buy
1,408,183
+466,030
+49% +$24.6M 0.72% 27
2013
Q4
$37.8M Buy
942,153
+636,900
+209% +$25.5M 0.38% 68
2013
Q3
$11.5M Buy
305,253
+15,160
+5% +$573K 0.13% 179
2013
Q2
$11.3M Buy
+290,093
New +$11.3M 0.13% 167